<DOC>
	<DOCNO>NCT02796469</DOCNO>
	<brief_summary>In specific set evaluation corticosteroid , pentoxifylline combination severe alcoholic hepatitis , meta-analysis combine individual data able provide detail information individual severe alcoholic hepatitis assess DF ≥ 32 . The need approach confirm fact univariate multivariate analysis , truth survival low conclusion meta-analysis literature conclusion derive non-meta-analyses . The present study meta-analysis individual data RCTs restrict patient DF ≥ 32 . The primary endpoint compare 28-day survival patient receive either corticosteroid , pentoxifylline combination patient receive adjusted independent prognostic factor baseline . The secondary endpoint : ) assessment response assign treatment use Lille model ; b ) analysis 6-month survival accord allocate therapy .</brief_summary>
	<brief_title>Meta-Analysis Drug Therapy Patients With Severe Alcoholic Hepatitis</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Hepatitis , Alcoholic</mesh_term>
	<mesh_term>Liver Diseases , Alcoholic</mesh_term>
	<mesh_term>Pentoxifylline</mesh_term>
	<criteria>patient include 10 randomize control trial test either corticosteroid alone , pentoxifylline alone combination publish .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>